Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010

JAMA

Volumn 308, Issue 20, 2012, Pages 2126-2132

  Misegades, Lara K ^a,b   Winter, Kathleen ^c   Harriman, Kathleen ^c   Talarico, John ^c   Messonnier, Nancy E ^b   Clark, Thomas A ^b   Martin, Stacey W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

EID: 84869792699     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.14939     Document Type: Article

References (32)

1. Centers for Disease Control and Prevention. National and state vaccination coverage among children aged 19-35 months - United States, 2010. MMWR Morb Mortal Wkly Rep. 2011;60(34):1157-1163.
2. Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, Coordinating Center for Health Information and Service, Centers for Disease Control and Prevention, US Department of Health and Human Services. National Notifiable Disease Surveillance System. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/pertussis/surv- reporting.html. Accessed October 29, 2012.
3. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981;68(5):650-660. (Pubitemid 11029708)
4. Long SS, Deforest A, Smith DG, Lazaro C, Wassilak GF. Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. Pediatrics. 1990;85(3):294-302. (Pubitemid 20064109)
5. Centers for Disease Control and Prevention. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-7):1-25.
6. Broder KR, Cortese MM, Iskander JK, et al Advisory Committee on Immunization Practices. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-3):1-34.
7. Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in pre-adolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730-1735.
8. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012-1019.
9. California Department of Health Services Immunization Branch. Pertussis Report. May 16, 2011. http://www.cdph.ca.gov/programs/immunize/Documents/ PertussisReport2011-05-16.pdf. Accessed December 8, 2011.
10. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1-55.
11. California Department of Public Health. Pertussis: CDPH Case Definition. July 1, 2010. http://www.cdph.ca.gov/programs/immunize/Documents/CDPH-Pertussis- case-definition-8-2010.pdf. Accessed October 24, 2011.
12. Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055-1068. (Pubitemid 16055438)
13. Rodrigues LC, Smith PG. Use of the case-control approach in vaccine evaluation: efficacy and adverse effects. Epidemiol Rev. 1999;21(1):56-72. (Pubitemid 29441985)
14. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
15. Fitzmaurice G. The odds ratio: impact of study design. Nutrition. 2000;16(11-12):1114-1115.
16. Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia, PA: WB Saunders; 2004:471-528.
17. Bisgard KM, Rhodes P, Connelly BL, et al Centers for Disease Control and Prevention. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics. 2005;116(2):e285-e294. (Pubitemid 44164238)
18. Centers for Disease Control and Prevention. Coverage With Individual Vaccines and Vaccination Series by State and Local Area: National Immunization Survey (NIS) - Children (19-35 Months), 2010. http://www.cdc.gov/vaccines/stats- surv/nis/data/tables-2010.htm. Accessed January 11, 2012.
19. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;2012(Jul):20.
20. Centers for Disease Control and Prevention. Pertussis epidemic - Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(28):517-522.
21. Mieszkowski K. Vaccination rate lags as an epidemic spreads. New York Times. July 10, 2010.
22. Friedrich MJ. Research aims to boost pertussis control. JAMA. 2011;306(1):27-29.
23. Préziosi MP, Halloran ME. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clin Infect Dis. 2003;37(6):772-779. (Pubitemid 37153655)
24. Bortolussi R, Miller B, Ledwith M, Halperin S. Clinical course of pertussis in immunized children. Pediatr Infect Dis J. 1995;14(10):870-874.
25. Grob PR, Crowder MJ, Robbins JF. Effect of vaccination on severity and dissemination of whooping cough. Br Med J (Clin Res Ed). 1981;282(6280):1925- 1928. (Pubitemid 11111189)
26. Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis. 1987;9(5):866-883.
27. Clark T. Pertussis epidemiology and program update. Presented at: National Immunization Conference; March 30, 2011; Washington, DC.
28. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(5)(suppl):S58-S61. (Pubitemid 40676539)
29. Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep. 1965;80:365-369.
30. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. Br Med J (Clin Res Ed). 1988;296(6622):612-614. (Pubitemid 18059445)
31. Cherry JD. Why do pertussis vaccines fail? Pediatrics. 2012;129(5):968-970.
32. Centers for Disease Control and Prevention. Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Recomm Rep. 1996;45(RR-13):1-16.